AvenCell Therapeutics

Biotechnology company developing next-generation universal (allogeneic) CAR-T cell therapies for cancer treatment, aiming to make cell therapy more accessible and affordable.

Location
Berlin, Germany
Founded
2019
Investors
1
Categories
biotech, cell-therapy, car-t, oncology, allogeneic-therapy

Investors

NameLocationTypeStagesPortfolio
Novo HoldingsHellerup, Denmarkbiotech-focused
seedseries-a+3
13